Table IV.
β | SE | t | p | |
---|---|---|---|---|
Level 2: between-person variables | ||||
Age | −1.42 | 0.57 | −2.49 | .02* |
Sex | 6.74 | 3.27 | 2.06 | .04* |
EMA—pain severity mean | −0.01 | 0.10 | −0.10 | .92 |
Level 1: within-person variables | ||||
EMA—pain severity previous day | −0.06 | 0.02 | −2.27 | .02* |
Interactions | ||||
Age×EMA—pain severity mean | −0.02 | 0.03 | −0.83 | .41 |
Age×EMA—pain severity previous day | −0.01 | 0.01 | −1.52 | .13 |
Note. The model controls for SCD genotype, current hydroxyurea prescription, and positive and negative mood. Level 2 EMA variables are all person-centered means. Level 1 EMA pain severity variable is from the evening report referencing pain the previous day. EMA = ecological momentary assessment; SCD = sickle cell disease; SE = standard error.
p < .05.